Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

PRISM : Peptide-specificity annotation of T-cell receptors with uncertainty quantification

Created on 05 Jul 2026

Authors

Venkatraman, D. L., Mok, L., Rose, N. R., Robinson, A., Jonsson, V. D.

Abstract

Mapping T-cell receptor (TCR) sequences to their cognate peptide-major histocompatibility complex (pMHC) ligands underlies both basic immunology and T-cell target discovery, yet current models aimed at predicting TCR specificity are limited by sparse labels, viral-biased training data, and an inability to recognize receptors outside their training distribution. We present PRISM, an uncertainty-aware metric-learning framework for TCR{beta} sequence representation. PRISM embeds receptors into a peptide-organized latent space, returns top-k peptides by nearest-neighbor retrieval, and abstains on out-of-distribution receptors by modeling an intrinsic uncertainty that tracks annotation correctness. To offset the viral bias of public databases, PRISM augments training data with structure-guided synthetic receptors that diversify TCR sequences while preserving the energetics of the TCR-pMHC interface. Across a held-out set of 923 peptides and the independent IMMREP23 benchmark, PRISM matches or exceeds sequence-based models, with largest gains on rare epitopes. Finally, PRISM learns attention weights on TCR residues that concentrate on the CDR3{beta} salt-bridge and hydrophobic contacts central to peptide recognition, linking PRISM's positional focus to the biochemical properties of TCR-pMHC structures.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 05 Jul 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement